Abstract Thiamine dependent enzymes are diminished in Alzheimer's disease (AD). Thiamine deficiency in vitro and in rodents is a useful model of this reduction. Thiamine interacts with cellular calcium stores. To directly test the relevance of the thiamine dependent changes to dynamic processes in AD, the interactions must be studied in cells from patients with AD. These studies employed fibroblasts. Mitochondrial dysfunction including reductions in thiamine dependent enzymes and abnormalities in calcium homeostasis and oxidative processes occur in fibroblasts from Alzheimer's Disease (AD) patients. Bombesin-releasable calcium stores (BRCS) from the endoplasmic reticulum (ER) are exaggerated in fibroblasts from patients with AD bearing a presenilin-1 (PS-1) mutation and in control fibroblasts treated with oxidants. ER calcium regulates calcium entry into the cell through capacitative calcium entry (CCE), which is reduced in fibroblasts and neurons from mice bearing PS-1 mutations. Under physiological conditions, mitochondria and ER play important and interactive roles in the regulation of Ca 2+ homeostasis. Thus, the interactions of mitochondria and oxidants with CCE were tested. Inhibition of ER Ca 2+ -ATPase by cyclopiazonic acid (CPA) stimulates CCE. CPA-induced CCE was diminished by inhibition of mitochondrial Ca 2+ export (−60 %) or import (−40 %). Different aspects of mitochondrial Ca 2+ coupled to CPA-induced-CCE were sensitive to select oxidants. The effects were very different when CCE was examined in the presence of InsP 3 , a physiological regulator of ER calcium release, and subsequent CCE. CCE under these conditions was only mildly reduced (20-25 %) by inhibition of mitochondrial Ca 2+ export, and inhibition of mitochondrial Ca 2+ uptake exaggerated CCE (+53 %). However, t-BHP reversed both abnormalities. The results suggest that in the presence of InsP 3 , mitochondria buffer the local Ca 2+ released from ER following rapid activation of InsP 3 R and serve as a negative feedback to the CCE. The results suggest that mitochondrial Ca 2+ modifies the depletion and refilling mechanism of ER Ca 2+ stores.
Introduction
Thiamine dependent enzymes are diminished in Alzheimer's disease (AD). Rodent thiamine deficiency (TD) has been used to model the mild impairment of metabolism that occurs in AD (Karuppagounder et al. 2009 ). TD exaggerates plaque and tangle formation in mouse models (Karuppagounder et al. 2009 ) and elevating thiamine levels diminish plaques, tangles and memory deficits (Pan et al. 2010 ). An understanding of the consequences of the reduction of thiamine dependent enzymes is important for understanding the pathophysiology of AD and for developing new therapies (Gibson et al. 2013) . Reduction of the thiamine dependent enzyme alphaketoglutarate dehydrogenase (KGDHC) either with an inhibitor or by genetic manipulation reveal that another consequence of diminished activity of a thiamine dependent enzyme is an alteration in the calcium stores in the endoplasmic reticulum. Thus, neurons taken from mice deficient in KGDHC have exaggerated stores of ER calcium whether the neurons are cultured from embryos or adults, just as in fibroblasts from patients with AD (Gibson et al. 2012) .
Whether this change occurs and is important in AD is more difficult to answer. Since the calcium change is dynamic one cannot measure this property in autopsy brain. A commonly used model to study disease processes is cultured fibroblasts. Indeed, fibroblasts were used by Dr. Butterworth in pioneering studies in the 1980s in which he looked at thiamine dependent enzymes in Leigh's disease in fibroblasts (Barbeau et al. 1976) . Surprisingly, the same abnormalities in calcium homeostasis that we observed by reducing a thiamine dependent enzyme in mouse brains occurs in fibroblasts from AD patients. BRCS from the endoplasmic reticulum (ER) are exaggerated in fibroblasts from patients with AD bearing a presenilin-1 (PS-1) mutation (Ito et al. 1994 ) and in control fibroblasts treated with specific oxidants (Huang et al. 2005) . The two oxidants employed in these studies were: (1) tert-Butyl-hydroperoxide (t-BHP) which produces the radicals tert-butyloxyl (t-bu-OS) and t-butylperoxyl (t-bu-OOS) and (2) 3-morpholinosydnonimine (SIN-1), which is commonly used to produce various forms of nitrogen monoxides that react with O 2 ._ to form peroxynitrite. A more detailed discussion is provided in (Huang et al. 2005) . The goal of the current study is to understand the consequences of these changes on cellular calcium regulation. Considerable research has been accomplished in understanding the increase in calcium in fibroblasts bearing presenilin-1 mutations leading to AD (Nelson et al. 2010) . However, these mechanisms only apply for patients bearing presenilin mutations. Thus, these interactions need be better understood in non-genetic forms of AD. The best cells to accomplish this are cells with a human genetic background (i.e., fibroblasts).
Calcium dynamics and the response of cells to oxidants are modified by thiamine (Huang et al. 2010) . Specific oxidants can induce the same changes in calcium dynamics that occur in fibroblasts from patients with AD (an exaggeration of BRCS) (Huang et al. 2005) . Further, the responses of cells to oxidants are modified by thiamine. Thiamine diminishes ER calcium stores, but does not alter CCE (Huang et al. 2010) .
The current studies test how these changes in ER calcium interact to regulate cellular calcium and the effects of oxidants on these responses. The mitochondria and ER are linked by proteins (mitochondrial associated proteins) that have been linked to proteins that underlie some genetic forms of AD (Area-Gomez et al. 2009 ). In addition, to the interaction between the ER and mitochondria there is a link between these processes and the ability to fill cellular calcium pools. The depletion of ER Ca 2+ content triggers Ca 2+ influx through plasma membrane Ca 2+ channels, a process known as capacitative calcium entry (CCE) (Putney & Ribeiro 2000) . CCE is reduced in fibroblasts and neurons from mice bearing PS-1 mutations (Leissring et al. 2000; Yoo et al. 2000) . Thus, genetic mutations that cause AD lead to increase intracellular calcium stores and an attenuation in the refilling mechanism CCE. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons (Chan et al. 2000) . Studies suggest that ER Ca 2+ disruption in AD is related to an enhancement of ryanodine receptor regenerative process (Stutzmann et al. 2006) . The ryanodine receptor is one of the Ca 2+ -release channels located on the ER which have been implicated in Ca 2+ -induced Ca 2+ release activity (CICR). In addition, oxidation of RyR results in activation of CICR (Hidalgo et al. 2000) .
Mitochondrial dysfunction may underlie altered calcium homeostasis in AD. Mitochondria may have a fundamental role in regulating CCE through bidirectional Ca 2+ -dependent crosstalk between mitochondria and CCE (Glitsch et al. 2002) . Mitochondria are often located near Ca 2+ release channels on the ER (Simpson et al. 1997) or Ca 2+ influx channels in the plasma membrane and modulate store-operated or CCE (Hoth et al. 1997) . Thus, mitochondria contribute to cellular Ca 2+ homeostasis in many cell types by taking up and releasing Ca 2 which propagates and synchronizes Ca 2+ signals (Pozzan et al. 1994) . Whether mitochondria act as a Ca 2+ sink or as a Ca 2+ relay mechanism, or whether the increase in mitochondrial Ca 2+ an essential step to activate CCE is unclear (Glitsch et al. 2002) .
The Ca 2+ buffering capacities of the ER and mitochondria can regulate CCE (Malli et al. 2003) . InsP 3 -mediated pathways regulate CCE and Ca 2+ uptake and release from mitochondria (Kojima & Ogata 1989) . Inhibition of the mitochondrial Na + /Ca 2+ exchanger with CGP37157 results in the increase of [Ca 2+ ] mito and reduces the ability of mitochondria to buffer subplasmalemmal Ca 2+ and leads to an increase of BKsensitive Ca 2+ channels activity and a decrease in CCE (Malli et al. 2003) . In addition, CGP37157 prevents complete Ca 2+ refilling of the ER during cell stimulation with an InsP 3 -generate agonist (Malli et al. 2005) .
Mitochondrial Ca 2+ uptake is operated by a high-capacity, low-affinity Ca 2+ uniporter, which can be inhibited specifically by Ru360. At sites where mitochondria are in close contact with the ER (Rizzuto et al. 1998) , micro-domains of high cytosolic Ca 2+ are generated by Ca 2+ release from ER through InsP 3 receptors (Rizzuto et al. 1999) . These high local cytosolic Ca 2+ concentrations lead to increases in mitochondrial Ca 2+ accumulation that correlate with increases in cytosolic Ca 2+ (Rizzuto et al. 1993 ) (Rizzuto et al. 1998) . Ru360 has no effect on Ca 2+ release from ER (Seguchi et al. 2005 (Huang et al. 2004 ). The present studies tested the interactions of mitochondria, ER Ca 2+ and CCE under control conditions as well as with oxidants or InsP 3 .
Materials and methods
The supplies were from the indicated companies: Cell culture r e a g e n t s ( G I B C O ; G r a n d I s l a n d , N Y ) ; 3 -morpholinosydnonimine (SIN-1) (Molecular Probes; Eugene, Oregon); bombesin, tert-butyl-hydroxyperoxide (t-BHP) (Sigma Chemical, St Louis, MO); CGP17157 and Ru360 (Calbiochem, San Diego, CA).
A human skin fibroblast cell line from a young male control (8,399) was purchased from Coriell Cell Repository (Camden, NJ). Cells were maintained exactly as described in our published protocol (Stutzmann et al. 2006 ).
Bombesin releasable calcium stores (BRCS)
Fluorescent intracellular calcium images were monitored as described previously (Huang et al. 2005; Huang et al. 2004 release, whereas it reduced the subsequent CCE (−39 %) ( exporter by CGP37157 diminished CCEFibroblasts were loaded with Fura 2 AM for 60 min. After loading, the media were changed to calcium free BSS, and 3 min later the calcium measurements were initiated. CGP37157 (20, 40 μM), an inhibitor of the mitochondrial Na + /Ca 2+ exchanger blocker was added after 1 min of basal [Ca 2+ ]i measurements, and CPA (2 μM) was added after 5 min. After an additional 2 min, CaCl 2 (final concentration of 2. Inhibition of mitochondrial Ca 2+ uptake by RU360 impaired CCE. Fibroblasts were loaded with Fura 2 AM (2 μM) for 60 min. After loading, the media were changed to calcium free BSS, and 3 min later the calcium measurements were initiated. The mitochondrial Ca 2+ uptake blocker Ru360 (0, 20 μM) was added 2 min after basal [Ca 2+ ] i measurements, and 4 min later CPA (2 μM) was added. Two min later CaCl 2 (final concentration of 2.5 mM) was added. The top panel shows the tracings taken from 50 to 51 cells. The bottom panel shows the integration of the [Ca 2+ ] i peak over the 3 min interval after calcium addition (495-720 s). Data are means ± SEM (n=50-51 cells). Different letters indicate values vary significantly (p<0.05) from the other groups by ANOVA followed by Student Newman Keul's test of Ca 2+ (0.625, 1.25 and 2.5 mM) were added to initiate CCE. The magnitude of CPA-induced elevation in CCE depended on the extracellular Ca 2+ concentrations. However, CCE was not modified by t-BHP at any concentration of calcium (Fig. 4) .
t-BHP but not SIN-1 attenuated the impairment of CCE by CGP37157
Previous studies demonstrated that tBHP increases BRCS just as occurs in AD (Huang et al. 2005) . The current studies extended that to CCE. The selective effects of oxidants were tested with a higher concentration of CPA. As shown in Fig. 1 , higher concentrations of CPA caused a larger increase in CCE which provides more opportunity for experimental manipulation. Cells were incubated in the absence of extracellular Ca 2+ . CGP37157 was added 1 min prior to addition of CPA (10 μM). Oxidants (t-BHP or SIN-1) were then added, and finally Ca 2+ was added to activate CCE. The mitochondrial Ca 2+ exporter inhibitor CGP37157 enhanced CPA-induced release Ca 2+ from ER (+129 % of CPA alone) and t-BHP further enhanced this Ca 2+ release from ER by 209 % of CPA treatment but SIN-1 did not alter the reduction by CGP37157 treatment (Fig. 5) . However, activation of CCE after CPA treatment was reduced by blockade of mitochondria Ca 2+ exporter by CGP37157 (−60 %) (Figs. 2, 5 ). This inhibitory effect of CGP was reversed by t-BHP (−22 %) but not by SIN-1 (Fig. 5) After loading, the media were changed to calcium free BSS, and 3 min later the calcium measurements were initiated. The CPA (10 μM) was added 1 min after CGP37157 (40 μM), t-BHP (100 μM) or SIN-1 (500 μM) was added 3 min later. After an additional 2 min CaCl 2 (final concentration of 2.5 mM) was added. (Fig. 7) . Thus, the impairment of CCE by CGP37157 was much less in the presence of InsP 3 (−20 %; Fig. 7) than that in the absence of InsP 3 agonist (−63 %; Fig. 2) . Thus, the impairment of CCE by a blocker of calcium export from the mitochondria was attenuated by InsP 3 .
In the presence of InsP 3 , blockade of mitochondrial Ca 2+ uptake exaggerated CCE Fibroblasts were treated with the mitochondrial Ca 2+ uptake inhibitor Ru360 prior to bombesin treatment, and subsequent re-addition Ca 2+ . Ru360 (10 or 20 μM) did not alter basal calcium (data not shown) but increased Ca 2+ release by bombesin (+81 %) and exaggerated the subsequent CCE significantly (+53 %) (Fig. 8) . This is in striking contrast with the results in the absence of InsP 3 where Ru360 diminished CCE (Fig. 3) .
In the presence of InsP 3 , impairment of CCE by blockade of mitochondrial Ca 2+ uptake inhibitor RU360. Fibroblasts were loaded with Fura 2 AM (2 μM) for 60 min. After loading, the media were changed to calcium free BSS, and 3 min later the calcium measurements were initiated. RU360 (0, 20 μM) was added 2 min after SIN-1 (500 μM). After an additional 4 min, CPA (2 μM) was added, and 2 min later CaCl 2 (final concentration of 2. In the presence of InsP3, blockade of mitochondrial Ca 2+ release had no effect on BRCS but impaired CCE. Fibroblasts were loaded with Fura 2 AM for 60 min. After loading, the media were changed to calcium free BSS, and 3 min later the calcium measurements were initiated. The CGP37157 (0, 20, 40 μM) was added after 1 min of basal [Ca 2+ ]i measurements, and bombesin (2 μM) was added after 3 min. After an additional 3 min, CPA (4 μM) was added, and 3 min later CaCl 2 (final concentration of 2.5 mM) was added. . CPA was added and finally Ca 2+ was added to activate CCE. The experiments show the effect of t-BHP on the results in Fig. 7 . CGP37157 did not alter BRCS but diminished subsequent CCE 29 % (Fig. 9) . Under the conditions, t-BHP enhanced BRCS (+139 %) which replicates our previous studies (Huang et al. 2005) . t-BHP also exaggerated the CCE (+34 %) (Fig. 9 ) and this increase was also blocked by CGP37157 (Fig. 9 ).
In the presence of InsP 3 , t-BHP attenuated the exaggeration of BRCS and CCE due to inhibition of mitochondrial Ca , and were treated with t-BHP one min prior to addition of inhibition of mitochondrial Ca 2+ uptake. Bombesin was then added to deplete ER Ca
2+
. CPA was added and finally Ca 2+ was added to activate CCE. The experiment shows the effects of oxidant on the results in Fig. 8 . Blockade of mitochondrial Ca 2+ uptake exaggerated BRCS and CCE by 82 % and 53 % of control, respectively (Fig. 8, 10 ). In addition, t-BHP exaggerated BRCS and CCE by 139 % and 34 % of control, respectively (Fig. 9, 10) . Interestingly, in the presence of InsP 3 , the oxidant t-BHP abolished the exaggeration of BRCS and CCE due to the inhibition of mitochondrial Ca 2+ uptake (Fig. 10) .
Discussion
The present studies demonstrated that CPA induced Ca 
Ru360
Fig . 8 In the presence of InsP 3 , blockade of mitochondrial Ca 2+ uptake by Ru360 exaggerated BRCS and subsequent CCE. Fibroblasts were loaded with Fura 2 AM (2 μM) for 60 min. After loading, the media were changed to calcium free BSS, and 3 min later the calcium measurements were initiated. Mitochondria Ca 2+ uptake blocker Ru360 (0, 10, 20 μM) was added after 1 min basal [Ca 2+ ] i measurements, and bombesin (1 μM) was added after 3 min. After additional 3 min, CPA (2 μM) was added, and 3 min later CaCl 2 (final concentration of 2.5 mM) was added. In the presence of InsP 3 , impairment of CCE by blockade of mitochondrial Ca 2+ release was attenuated by t-BHP. Fibroblasts were loaded with Fura 2 AM (2 μM) for 60 min. After loading, the media were changed to calcium free BSS, and 3 min later the calcium measurements were initiated. CGP37157 (20 μM) was added 1 min after t-BHP (100 μM) treatment, and bombesin (1 μM) was added after 3 min. After an additional 2 min, CPA (2 μM) was added, and 2 min later CaCl 2 (final concentration of 2. . The concentration dependent increase in cytosolic calcium after CPA indicates that greater inhibition of the Ca 2+ ATPase leads to greater release of ER calcium. The release of ER calcium activates CCE even in the absence of increases in cytosolic free calcium (i.e. at low CPA concentrations) (Fig. 1) . Under this condition, impairment of the mitochondrial Ca 2+ export system (Fig. 2) or uptake system (Fig. 3 ) attenuated CCE. The inhibitory effect of CGP37157 on CCE suggests that mitochondrial Ca 2+ release has a direct impact on the activation of CCE (Fig. 2, 11) . The reduction of CCE by Ru360 (−40 %) without an alteration in cytosolic calcium suggests that mitochondrial calcium uptake is directly linked to CCE (Fig. 3) . Thus, mitochondria play an important role in the regulation of the CCE following depletion of the ER Ca
2+
. The results suggest that Ca 2+ release from mitochondria contributes to the activation of CCE either directly or indirectly.
CCE can be regulated at several possible sites (Fig. 11 . The -number after the figure number refers to the number on the figure): including passive leak of ER Ca 2+ (Fig. 11-1) , mitochondrial Ca 2+ release-refilling to ER (Fig. 11-2 ), Ca 2+ uptake by mitochondria (Fig. 11-3) , Ca 2+ influx across plasma membrane (Fig. 11-4) . When the ER Ca-ATPase is inhibited, a reduction of mitochondrial Ca 2+ release markedly enhanced cytosolic Ca 2+ elevation and reduced subsequent CCE (− 56 %). Thus, the results suggest that mitochondrial Ca 2+ release serve as ER refilling mechanism (Fig. 11-2) . In other words, the mitochondria Ca 2+ directly fill the ER stores, which is the signal for the CCE. Ru360 impaired the CCE (−40 %) without altering cytosolic Ca
. Thus suggests that mitochondria uptake Ca 2+ influx directly affects CCE. Perhaps the mitochondria regulate localized calcium concentrations ( Fig. 11-3 ). However, in the absence of CPA, the addition of Ca 2+ increased cytosolic free calcium also activated CCE (19.8 % of that with CPA), suggesting that Ca 2+ influx is independent of either the mitochondria or the ER (Fig. 11-4) . Therefore, the results suggest that CCE can be regulated by passive leak of ER Ca 2+ (Fig. 11-1 ), mitochondrial Ca 2+ release to refill ER calcium ( Fig. 11-2 ), Ca 2+ uptake by mitochondria (Fig. 11-3 ), Ca 2+ influx across the plasma membrane ( Fig. 11-4) .
Selective oxidants affect different sites of regulation of CCE. The present studies showed that t-BHP had no effect on CCE (Fig. 4) . These results suggest that the t-BHP must promote calcium entry either by facilitating calcium export from the mitochondria or by facilitating calcium entry into the ER from other sources. This effect is oxidant selective because SIN-1 is ineffective in this regard. These results are in agreement with our previous studies (Huang et al. 2005 ) which showed that t-BHP but not SIN-1, increased ER calcium stores. On the other hand, SIN-1 did overcome the inhibition Intracellular Calcium (nM) In the presence of InsP3, t-BHP diminished the exaggeration of BRCS and CCE due to the inhibition of the mitochondrial Ca 2+ uptake. Fibroblasts were loaded with Fura 2 AM (2 μM) for 60 min. After loading, the media were changed to calcium free BSS, and 3 min later the calcium measurements were initiated. The mitochondrial Ca 2+ uptake blocker Ru360 (20 μM) was added 2 min after t-BHP (100 μM), and bombesin (1 μM) was added after 2 min. After additional 2 min, CPA (2 μM) was added, and 2 min later CaCl 2 (final concentration of 2.5 mM) was added. The top panel shows the tracings taken from 69 to 106 cells. The bottom panel shows the integration of the [Ca 2+ ] i peak over the 3 min interval after bombesin or calcium addition. Data are means±SEM (n= 69-106cells (4) of CCE that was caused by inhibition of mitochondrial calcium uptake (Fig. 6) . Taken together the results suggest that CCE regulated by mitochondrial Ca 2+ release-refilling to ER ( Fig. 11-2 ) is sensitive to t-BHP, while CCE regulated by mitochondrial Ca 2+ uptake can be modified by the action of SIN-1 (Fig. 11-3) . CCE regulated by ER Ca 2+ passive leak pathway is not sensitive to t-BHP (Fig. 4, Fig. 11-1) . The results suggest that Ca 2+ release from mitochondria contributes to the activation of CCE either directly or indirectly and can be modified by select oxidants.
These interactions are modified in the presence of the InsP 3 producing agonist bombesin (Fig. 12) . Impairment of mitochondrial Ca 2+ release by CGP37157 impaired CCE (Fig. 7) , suggesting that mitochondrial Ca 2+ play a role to regulate CCE. CGP37157 prevents Ca 2+ refilling of the ER during cell stimulation with an InsP 3 -producing agonist (Malli et al. 2005) . The impairment of CCE by CGP37157 was much less in the presence of InsP 3 -producing agonist (−25 %) than in its absence (−56 %). In the absence of InsP 3 producing agonist, ER Ca 2+ was not up taken by mitochondria. However, mitochondria can uptake and release Ca 2+ during cell stimulation with InsP 3 -produdcing agonists, thereby generating subplasmalemmal microdomains of low Ca 2+ that sustain activity of CCE (Malli et al. 2005) . Thus, mitochondrial Ca 2+ uptake from the local transient Ca 2+ release from ER via activation of InsP 3 receptor (Fig. 12-1 ) is a major source for refilling ER by mitochondria Na + /Ca 2+ exchanger ( Fig. 12-2 ). Other studies that directly measured mitochondrial Ca 2 show that in the absence of InsP 3 agonist, CGP37157 has no effect on mitochondrial Ca 2+ , while in the presence of InsP 3 agonist, CGP37157 leads to a longelevation of mitochondrial Ca 2+ (Malli et al. 2005 (Figs. 8, 10, 11, 12) . The results with Ru360 in the presence (Fig. 11) and absence ( Fig. 12) of InsP 3 producing agonist are opposite. Cytosolic Ca 2+ signals elicited by activation of InsP 3 R or RyR are transmitted to the mitochondria (Rizzuto et al. 1998; Rizzuto et al. 1993; Hajnoczky et al. 1995) (Fig. 12-1) . Thus, calcium moves from the ER to the mitochondria without mixing with the cytosol. Furthermore, mitochondrial Ca 2+ transport modulates the spatio-temporal pattern of cytosolic Ca 2+ responses evoked by InsP 3 . As shown in Fig. 12 , mitochondrial Ca 2+ uptake limits the rate of propagation of calcium induced calcium release (CICR) which leads to activation of RyR. Therefore, disabling mitochondrial Ca 2+ uptake will increase the rate of CICR which requires Ca 2+ released locally by InsP 3 acting in the ER Ca 2+ stores (Fig. 12-3) . The greatest emptying of ER Ca 2+ occurred with the combination of InsP 3 R and CICR (Figs. 8, 10 as indicating by higher BRCS), and this produced higher CCE (Figs. 8, 10 , Fig. 12-4 (Lin et al. 2005) .
In the presence of InsP 3 , t-BHP reversed the abnormalities caused by the disruptions of uptake or release of mitochondrial Ca 2+ (Fig. 9 , 10, 12), suggesting t-BHP-induced ROS signaling regulated this mitochondrial and ER Ca 2+ signals. Oxidant t-BHP exaggerated Ca 2+ release from ER and elevated CCE replicated our previous studies (Huang et al. 2005) . t-BHP independently exaggerated the elevation of Ca 2+ release from ER and impaired CCE by blocking mitochondrial Ca 2+ release. The t-BHP-induced exaggeration in CCE may be due to an oxidant-induced exaggeration in the ability of bombesin to deplete InsP 3 sensitive calcium stores (i.e. increased BRCS) and subsequent CICR. The ryanodine receptor channel is a thiols protein, which is S-nitrosylated and results to a progressive channel activation (Xu et al. 1998) . However, oxidation of additional thiols (or of another class of thiols) produces irreversible activation can lead to loss of control (Xu et al. 1998) . The disruption that ER Ca 2+ regulation in AD has been suggested to be related to an enhancement of ryanodine receptor (Stutzmann et al. 2006 ). In the presence of InsP 3 , the mitochondria buffer the elevation of Ca 2+ by the InsP 3 receptor, and refill the ER Ca
. If the Ca 2+ released by InsP 3 is not up taken by mitochondria, Ca2 + will facilitate the rate of CICR. In addition, t-BHP facilitated InsP3 and RyR activation and compensated mitochondria-ER refilling process (Fig. 12-5 (Boehning et al. 2003) . Phospholipase C and polyphosphoinositides are required for the activation of the CCE (Broad et al. 2001 ).
Summary
An understanding of the interaction of cellular calcium stores with oxidants and InsP 3 is necessary to determine how these are altered in AD, and to develop therapies directed at the calcium dysregulation in AD. Mitochondrial Ca 2+ plays an important role in the regulation of the CCE following depletion of the ER, and the mechanisms differ in the presence and absence of InsP 3 producing agonist. Inhibition of mitochondrial Ca 2+ uptake impaired the CCE in the absence of InsP 3 producing agonist, whereas it enhanced CCE activity in the presence of InsP 3 producing agonist. The results suggest that in the presence of InsP 3 , mitochondria buffer the local Ca 2+ released from ER following rapid InsP 3 Ca 2+ induced release, and serve as a negative feedback to the CCE. In the presence of InsP 3 , blocking mitochondrial calcium release and uptake impaired and exaggerated CCE, respectively and these abnormalities could be reversed by t-BHP. On the other hand, impaired CCE by inhibition of mitochondrial Ca 2+ uptake in the absence of InsP 3 could be diminished by SIN-1. Thus, selective oxidants regulated the interactions of mitochondria with CCE whether or not the InsP 3 producing agonist is present. Now that these interactions have been defined in a control line, the changes with AD can be delineated and strategies to ameliorate the abnormalities can be developed.
